Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial.

Houston BL, Lawler PR, Goligher EC, Farkouh ME, Bradbury C, Carrier M, Dzavik V, Fergusson DA, Fowler RA, Galanaud JP, Gross PL, McDonald EG, Husain M, Kahn SR, Kumar A, Marshall J, Murthy S, Slutsky AS, Turgeon AF, Berry SM, Rosenson RS, Escobedo J, Nicolau JC, Bond L, Kirwan BA, de Brouwer S, Zarychanski R

Open source

DOI: 10.1177/1740774520943846
Published: 2020 Oct
Container: Clinical trials (London, England)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/1740774520943846,
  title = {Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial.},
  author = {Houston BL and Lawler PR and Goligher EC and Farkouh ME and Bradbury C and Carrier M and Dzavik V and Fergusson DA and Fowler RA and Galanaud JP and Gross PL and McDonald EG and Husain M and Kahn SR and Kumar A and Marshall J and Murthy S and Slutsky AS and Turgeon AF and Berry SM and Rosenson RS and Escobedo J and Nicolau JC and Bond L and Kirwan BA and de Brouwer S and Zarychanski R},
  year = {2020},
  journal = {Clinical trials (London, England)},
  doi = {10.1177/1740774520943846},
  url = {https://doi.org/10.1177/1740774520943846}
}

RIS

TY  - JOUR
TI  - Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial.
AU  - Houston BL
AU  - Lawler PR
AU  - Goligher EC
AU  - Farkouh ME
AU  - Bradbury C
AU  - Carrier M
AU  - Dzavik V
AU  - Fergusson DA
AU  - Fowler RA
AU  - Galanaud JP
AU  - Gross PL
AU  - McDonald EG
AU  - Husain M
AU  - Kahn SR
AU  - Kumar A
AU  - Marshall J
AU  - Murthy S
AU  - Slutsky AS
AU  - Turgeon AF
AU  - Berry SM
AU  - Rosenson RS
AU  - Escobedo J
AU  - Nicolau JC
AU  - Bond L
AU  - Kirwan BA
AU  - de Brouwer S
AU  - Zarychanski R
PY  - 2020
JO  - Clinical trials (London, England)
DO  - 10.1177/1740774520943846
UR  - https://doi.org/10.1177/1740774520943846
ER  -

APA

BL, H., PR, L., EC, G., ME, F., C, B., M, C., V, D., DA, F., RA, F., JP, G., PL, G., EG, M., M, H., SR, K., A, K., J, M., S, M., AS, S., AF, T., SM, B., RS, R., J, E., JC, N., L, B., BA, K., S, D. B., & R, Z. (2020). Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial.. Clinical trials (London, England). https://doi.org/10.1177/1740774520943846

Source records

pubmed · retrieved 2026-09-25T17:07:36.101Z